Cancer treatment company plans for public offeringJuly 25, 2019PetCure Oncology has engaged Boustead Securities for a Regulation D 506(c) offering.
SPONSORED CONTENTSlow Down MMVD in DogsHelp dogs enjoy a prolonged, symptom-free period with early diagnosis/management of MMVD. + Learn More